Pharmaceutical firms work to tweak vaccines against new variant

Pharmaceutical firms are looking at how vaccines might be tweaked against the new variant )PA)

Work is under way to tweak vaccines against the new concerning strain of coronavirus that has sparked travel bans.

The strain, named Omicron and designated a “variant of concern” by the World Health Organisation (WHO), has reached Belgium after being discovered in South Africa.